Skip to main content
Log in

Corticosteroid effect on early beta-adrenergic down-regulation durign circulatory shock: Hemodynamic study and beta-adrenergic receptor assay

  • Original
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

Abstract

Objectives

The steroid effect on critically ill patients remains controversial. The aim of this study is to characterize the effect of methylprednisolone on the heart in a beta-adrenergically downregulated condition.

Design

A prospective hemodynamic study and retrospective receptor assay.

Setting

Multidisciplinary ICU in a university hospital.

Subjects

42 patients who required pulmonary arterial catheters and an additional 4 corpses who were available for study within 3 h of their deaths.

Intervention

Intravenous methylprednisolone (10 mg/kg).

Measurements and results

We pursued a hemodynamic study following a glucocorticoid administration. In patients who had undergone a long term (>72 h) catecholamine treatment, the cardiac index increased. In patients who had undergone a short term (1–72 h) catecholamine treatment and in patients with no record of catecholamine administration, the cardiac index showed no remarkable change. Among the corpuses, who died soon after their arrival, and the patients, who later died in the ward and were available for further study, we measured beta-adrenergic receptor density in the left ventricular myocardium. It was found that receptor density was decreased after long term catecholamine treatment. Methylprednisolone, on the other hand increased the receptor density.

Conclusion

Methylprednisolone improved the cardiac index, intriguingly, in patients with long term catecholamine treatment in circulatory shock. Myocardial beta-adrenergic receptor also increased in number after the administration of methylprednisolone. However, the hemodynamic improvement caused by methylprednisolone was not observed in patients without beta-adrenergic down-regulation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Colucci WS, Wright RF, Braunwald E (1986) New positive inotropic agents in the treatment of congestive heart failure. N Engl J Med 314:290–296

    PubMed  Google Scholar 

  2. Spitzer JA, Rodriguiez de Turco EB, Deaciuc IV, Roth BL, Hermiller JB, Mehegan JP (1989) Receptor changes in endotoxemia. In: Passmore JC (ed) Perspective in shock research. Liss, New York, pp 95–106

    Google Scholar 

  3. Sibley DR, Lefkowitz RJ (1985) Molecular mechanisms of receptor desensitization using the β-adrenergic receptorcoupled adenylate cyclase system as a model. Nature 317:124–129

    PubMed  Google Scholar 

  4. Colucci WS, Alexander RW, Williams GH, Braunwald E (1981) Decreased lymphocyte beta-adrenergic-receptor density in patients with heart failure and tolerance to the beta-adrenergic agonist pirbuterol. N Engl J Med 305:185–190

    PubMed  Google Scholar 

  5. Unverferth DV, Blanford M, Kates RE (1980) Tolerance to dobutamine after a 72-hour continuous infusion. Am J Med 69:262–266

    PubMed  Google Scholar 

  6. Collins S, Caron MG, Lefkowitz RJ (1988) Beta-adrenergic receptors in hamster smooth muscle cells are transcriptionally regulated by glucocorticoids. J Biol Chem 263:9067–9070

    PubMed  Google Scholar 

  7. Davies AO, Lefkowitz RJ (1983) In vitro desensitization of beta adrenergic receptors in human neutrophils. Attenuation by corticosteroids. J Clin Invest 71:565–571

    PubMed  Google Scholar 

  8. Davies AO, Lefkowitz RJ (1980) Corticosteroid induced differential regulation of β-adrenergic receptors in circulating human polymorphonuclear leukocytes and mononuclear leukocytes. J Clin Endocrinol Metab 51:599–605

    PubMed  Google Scholar 

  9. Ogawa T, Shingu K, Magaribuchi T, Nakao S, Tamai S, Shindo K, Mori K (1990) Granulocyte β-adrenoceptor density increased with methylprednisolon in patients receiving dopamine infusion. Masui (Japanese, Japanese J in Anesthesiology) 39:1694–1700

    Google Scholar 

  10. Saito T, Yamada K, Kitamura A, Ishihara Y, Amamoto H, Ogawa R (1992) Corticosteroid effect on downregulation in beta adrenergic receptors. J Anesth 6:226–228

    PubMed  Google Scholar 

  11. Sugiyama S, Hayashi K, Hanaki Y, Taki K, Ozawa T (1991) Effect of methylprednisolone on recovery of β-adrenergic desensitization in rat hearts. Arzneimittelforsch/Drug Res 41:439–443

    Google Scholar 

  12. Barash PG, Cullen BF, Stoelting RK (1989) Clinical anesthesia. Lippincott Philadelphia, pp 575

    Google Scholar 

  13. Endoh M, Takanashi M, Norota I (1992) Effect of (+)-niguldipine on myocardial alpha1-adrenoceptors in the rabbit. Eur J Phrmacol 223:143–151

    Google Scholar 

  14. Sato T, Bewtra AK, Hoppo RJ, Nair N, Townley RG (1990) Alpha-and beta-adrenergic receptor systems in bronchial asthma and in subjects without asthma. J Allergy Clin Immunol 86:839–850

    PubMed  Google Scholar 

  15. Mano K, Akbarzadeh A, Townley RG (1979) Effect of hydrocortisone on beta-adrenergic receptors in lung membranes. Life Sci 25:1925–1930

    PubMed  Google Scholar 

  16. Scatchard G (1949) The attractions of proteins for small molecules and ions. Ann NY Acad Sci 51:660–672

    Google Scholar 

  17. Abraham E, Bland RD, Cobo JC, Shoemaker WC (1984) Sequential cardiorespiratory patterns associated with outcome in septic shock. Chest 85: 75–80

    PubMed  Google Scholar 

  18. Creamer JE, Edwards JD, Nightingale P (1989) Monitoring of hemodynamic and oxygen transport variables in cardiogenic shock (Abstr) Br J Hosp Med 40:402

    Google Scholar 

  19. Edwards JD, Redmond AD, Nightingale P, Wilkins RG (1988) Oxygen consumption following trauma. Br J Surg 75:690–692

    PubMed  Google Scholar 

  20. Haupt MT, Gilbert EM, Carlson RW (1985) Fluid loading increases oxygen delivery and consumption in septic patients with lactic acidosis. Am Rev Respir Dis 131:912–916

    PubMed  Google Scholar 

  21. Unverferth DV, Magorien RD, Lewis RP, Leier CV (1980) Long-term benefit of dobutamine infusions for patients awaiting cardiac tranplantation. Am Heart J 100:622–630

    PubMed  Google Scholar 

  22. Kell MJ, Kline EM, Bates ER, Hodgson JM, Dilworth LR, Laufer N, Vogel RA, Pitt B (1986) Intermittent ambulatory dobutamine infusions in patients with severe congestive heart failure. Am Heart J 112:787–791

    PubMed  Google Scholar 

  23. Shoemaker WC, Appel PL, Kram HB, Duart D, Harrier D, Ocampo HA (1989) Comparison of hemodynamic and oxygen transport effects of dobutamine and dopamine in critically ill surgical patients. Chest 96:120–126

    PubMed  Google Scholar 

  24. Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, Billingham M, Harrison DC, Stinson ED (1982) Decreased catecholamine sensitivity and β-adrenergic receptor density in failing human hearts. N Engl J Med 307:205–211

    PubMed  Google Scholar 

  25. Vatner DE, Vatner SF, Nejima J, Uemura N, Susanni EE, Hintze TH, Homcy CJ (1989) Chronic norepinephrine elicit desensitization by uncoupling the beta-receptor. J Clin Invest 84:1741–1748

    PubMed  Google Scholar 

  26. Lee T-S, Virtusio L (1991) Methylprednisolon: A Myocardial Depressant? Crit Care Med 19:S9

    Google Scholar 

  27. Emele JF, Bonnycastle DD (1956) Cardiotonic activity of some adrenal steroids. Am J Physiol 185:103–106

    PubMed  Google Scholar 

  28. Karliner JS, Simpson PC, Norman H, Woloszyn W (1986) Mechanisms and time course of beta 1-adrenoceptor desensitisation in mammalian cardiac myocytes. Cardiovasc Res 20:221–228

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Institute for Drug Discovery Research Yamanouchi Pharmaceutical Co. Ltd.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Saito, T., Takanashi, M., Gallagher, E. et al. Corticosteroid effect on early beta-adrenergic down-regulation durign circulatory shock: Hemodynamic study and beta-adrenergic receptor assay. Intensive Care Med 21, 204–210 (1995). https://doi.org/10.1007/BF01701473

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01701473

Key words

Navigation